Speaker: Olatunji Alese

0:00:48

Siltuximab and spartalizumab in advanced pancreatic adenocarcinoma

0:00:36

Exploiting DNA damage in colorectal cancer to improve patient survival

0:00:29

Nipavect: niraparib and panitumumab in RAS-wild type colorectal cancer

0:00:24

Downstaging methods for microsatellite instability colorectal cancer

0:00:34

Advancing colorectal cancer treatment: molecular profiling for expanded therapeutic

0:00:40

The limited therapeutic efficacy of checkpoint inhibitors for pancreatic cancer

0:00:43

OniLon: trifluridine/tipiracil with nanoliposomal irinotecan in advanced CRC

0:01:12

Challenges in implementing genomic testing for metastatic colorectal cancer

0:00:46

PROSPECT: neoadjuvant CRT vs FOLFOX in locally advanced rectal cancer

0:00:56

Adjuvant chemotherapy in biliary tract cancer post-tumor resection

1:11:20

Saima Muzahir, MD Sequencing of Systemic Therapy & PRRT in NETs